Literature DB >> 33549162

Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records.

Jonathan Pearson-Stuttard1, James Bennett2, Yiling J Cheng3, Eszter P Vamos4, Amanda J Cross5, Majid Ezzati2, Edward W Gregg2.   

Abstract

BACKGROUND: The prevalence of diabetes has increased in the UK and other high-income countries alongside a substantial decline in cardiovascular mortality. Yet data are scarce on how these trends have changed the causes of death in people with diabetes who have traditionally died primarily of vascular causes. We estimated how all-cause mortality and cause-specific mortality in people with diabetes have changed over time, how the composition of the mortality burden has changed, and how this composition compared with that of the non-diabetes population.
METHODS: In this epidemiological analysis of primary care records, we identified 313 907 individuals with diabetes in the Clinical Practice Research Datalink, a well described primary care database, between 2001 to 2018, and linked these data to UK Office for National Statistics mortality data. We assembled serial cross sections with longitudinal follow-up to generate a mixed prevalence and incidence study population of patients with diabetes. We used discretised Poisson regression models to estimate annual death rates for deaths from all causes and 12 specific causes for men and women with diabetes. We also identified age-matched and sex matched (1:1) individuals without diabetes from the same dataset and estimated mortality rates in this group.
FINDINGS: Between Jan 1, 2001, and Oct 31, 2018, total mortality declined by 32% in men and 31% in women with diagnosed diabetes. Death rates declined from 40·7 deaths per 1000 person-years to 27·8 deaths per 1000 person-years in men and from 42·7 deaths per 1000 person-years to 29·5 deaths per 1000 person-years in women with diagnosed diabetes. We found similar declines in individuals without diabetes, hence the gap in mortality between those with and without diabetes was maintained over the study period. Cause-specific death rates declined in ten of the 12 cause groups, with exceptions in dementia and liver disease, which increased in both populations. The large decline in vascular disease death rates led to a transition from vascular causes to cancers as the leading contributor to death rates in individuals with diagnosed diabetes and to the gap in death rates between those with and without diabetes.
INTERPRETATION: The decline in vascular death rates has been accompanied by a diversification of causes in individuals with diagnosed diabetes and a transition from vascular diseases to cancers as the leading contributor to diabetes-related death. Clinical and preventative approaches must reflect this trend to reduce the excess mortality risk in individuals with diabetes. FUNDING: Wellcome Trust.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33549162      PMCID: PMC7886654          DOI: 10.1016/S2213-8587(20)30431-9

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   44.867


  31 in total

Review 1.  Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease.

Authors:  Keith G Tolman; Vivian Fonseca; Anthony Dalpiaz; Meng H Tan
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

2.  Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial.

Authors:  Tali Cukierman-Yaffe; Hertzel C Gerstein; Helen M Colhoun; Rafael Diaz; Luis-Emilio García-Pérez; Mark Lakshmanan; Angelyn Bethel; Denis Xavier; Jeffrey Probstfield; Matthew C Riddle; Lars Rydén; Charles Messan Atisso; Stephanie Hall; Purnima Rao-Melacini; Jan Basile; William C Cushman; Edward Franek; Matyas Keltai; Fernando Lanas; Lawrence A Leiter; Patricio Lopez-Jaramillo; Valdis Pirags; Nana Pogosova; Peter J Raubenheimer; Jonathan E Shaw; Wayne H-H Sheu; Theodora Temelkova-Kurktschiev
Journal:  Lancet Neurol       Date:  2020-07       Impact factor: 44.182

3.  Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data.

Authors:  Edward W Gregg; Yiling J Cheng; Meera Srinivasan; Ji Lin; Linda S Geiss; Ann L Albright; Giuseppina Imperatore
Journal:  Lancet       Date:  2018-05-18       Impact factor: 79.321

Review 4.  Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies.

Authors:  Konstantinos K Tsilidis; John C Kasimis; David S Lopez; Evangelia E Ntzani; John P A Ioannidis
Journal:  BMJ       Date:  2015-01-02

5.  Achievement of goals in U.S. diabetes care, 1999-2010.

Authors:  Mohammed K Ali; Kai McKeever Bullard; Jinan B Saaddine; Catherine C Cowie; Giuseppina Imperatore; Edward W Gregg
Journal:  N Engl J Med       Date:  2013-04-25       Impact factor: 91.245

6.  Age-Specific Trends From 2000-2011 in All-Cause and Cause-Specific Mortality in Type 1 and Type 2 Diabetes: A Cohort Study of More Than One Million People.

Authors:  Jessica L Harding; Jonathan E Shaw; Anna Peeters; Susan Davidson; Dianna J Magliano
Journal:  Diabetes Care       Date:  2016-04-26       Impact factor: 19.112

7.  Data Resource Profile: Clinical Practice Research Datalink (CPRD).

Authors:  Emily Herrett; Arlene M Gallagher; Krishnan Bhaskaran; Harriet Forbes; Rohini Mathur; Tjeerd van Staa; Liam Smeeth
Journal:  Int J Epidemiol       Date:  2015-06-06       Impact factor: 7.196

8.  The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis.

Authors:  Gitanjali M Singh; Goodarz Danaei; Farshad Farzadfar; Gretchen A Stevens; Mark Woodward; David Wormser; Stephen Kaptoge; Gary Whitlock; Qing Qiao; Sarah Lewington; Emanuele Di Angelantonio; Stephen Vander Hoorn; Carlene M M Lawes; Mohammed K Ali; Dariush Mozaffarian; Majid Ezzati
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

9.  Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study.

Authors:  Melanie Calvert; Aparna Shankar; Richard J McManus; Helen Lester; Nick Freemantle
Journal:  BMJ       Date:  2009-05-26

10.  Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

Authors: 
Journal:  Lancet       Date:  2016-04-06       Impact factor: 79.321

View more
  32 in total

1.  Involvement of Paired Immunoglobulin-like Receptor B in Diabetes-Associated Cognitive Dysfunction Through Modulation of Axon Outgrowth and Dendritic Remodeling.

Authors:  Kairui Pu; Meiyan Wu; Tao Jiang; Yuxin Zhang; Mao Ye; Jianyu Sun; Hongli Ma; Qian Zhai; Qiang Wang
Journal:  Mol Neurobiol       Date:  2022-01-29       Impact factor: 5.590

2.  Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China.

Authors:  Yan-Bo Zhang; Xiong-Fei Pan; Qi Lu; Yan-Xiu Wang; Ting-Ting Geng; Yan-Feng Zhou; Linda M Liao; Zhou-Zheng Tu; Jun-Xiang Chen; Peng-Fei Xia; Yi Wang; Zhen-Zhen Wan; Kun-Quan Guo; Kun Yang; Han-Dong Yang; Shuo-Hua Chen; Guo-Dong Wang; Xu Han; Yi-Xin Wang; Danxia Yu; Mei-An He; Xiao-Min Zhang; Lie-Gang Liu; Tangchun Wu; Shou-Ling Wu; Gang Liu; An Pan
Journal:  Diabetologia       Date:  2022-09-14       Impact factor: 10.460

3.  Combined treatment with glucagon-like peptide-1 receptor agonist exendin-4 and metformin attenuates breast cancer growth.

Authors:  Yuki Tanaka; Chikayo Iwaya; Takako Kawanami; Yuriko Hamaguchi; Tsuyoshi Horikawa; Toru Shigeoka; Toshihiko Yanase; Daiji Kawanami; Takashi Nomiyama
Journal:  Diabetol Int       Date:  2021-11-25

4.  Association of SGLT2 inhibitors with lower incidence of death in type 2 diabetes mellitus and causes of death analysis.

Authors:  Mu-Chi Chung; Hui-Tsung Hsu; Chao-Hsiang Chang; Peir-Haur Hung; Po-Jen Hsiao; Laing-You Wu; Ming-Ju Wu; Jeng-Jer Shieh; Chi-Jung Chung
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

5.  Risk trajectories of complications in over one thousand newly diagnosed individuals with type 2 diabetes.

Authors:  Gudrun Höskuldsdóttir; Stefan Franzén; Katarina Eeg-Olofsson; Björn Eliasson
Journal:  Sci Rep       Date:  2022-07-11       Impact factor: 4.996

6.  Hyperglycemia alters N-glycans on colon cancer cells through increased production of activated monosaccharides.

Authors:  H F Loponte; I A Oliveira; B C Rodrigues; R Nunes-da-Fonseca; R Mohana-Borges; F Alisson-Silva; W B Dias; A R Todeschini
Journal:  Glycoconj J       Date:  2022-04-05       Impact factor: 3.009

7.  Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults With Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD Study.

Authors:  Rena R Wing; George A Bray; Maria Cassidy-Begay; Jeanne M Clark; Mace Coday; Caitlin Egan; Mary Evans; John P Foreyt; Stephen Glasser; Edward W Gregg; Helen P Hazuda; James O Hill; Edward S Horton; Juan Carlos Isaac; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Stephen Kritchevsky; E Lewis; Nisa M Maruthur; Barbara J Maschak-Carey; David M Nathan; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; David Reboussin; Donna H Ryan; Valerie Ruelas; Helmut Steinburg; Katie Toledo; Thomas A Wadden; Lynne E Wagenknecht; Jacqueline Wesche-Thobaben; Holly Wyatt; Susan Z Yanovski; Ping Zhang
Journal:  Diabetes Care       Date:  2022-03-21       Impact factor: 17.152

8.  Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.

Authors:  Christine G Lee; Brandy Heckman-Stoddard; Dana Dabelea; Kishore M Gadde; David Ehrmann; Leslie Ford; Philip Prorok; Edward J Boyko; Xavier Pi-Sunyer; Amisha Wallia; William C Knowler; Jill P Crandall; Marinella Temprosa
Journal:  Diabetes Care       Date:  2021-10-25       Impact factor: 19.112

9.  Effects of a Self-Prepared Carbohydrate-Reduced High-Protein Diet on Cardiovascular Disease Risk Markers in Patients with Type 2 Diabetes.

Authors:  Ahmad H Alzahrani; Mads J Skytte; Amirsalar Samkani; Mads N Thomsen; Arne Astrup; Christian Ritz; Jan Frystyk; Jens J Holst; Sten Madsbad; Steen B Haugaard; Thure Krarup; Thomas M Larsen; Faidon Magkos
Journal:  Nutrients       Date:  2021-05-17       Impact factor: 5.717

Review 10.  Exercise-A Panacea of Metabolic Dysregulation in Cancer: Physiological and Molecular Insights.

Authors:  Steffen H Raun; Kristian Buch-Larsen; Peter Schwarz; Lykke Sylow
Journal:  Int J Mol Sci       Date:  2021-03-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.